Reply to te Brake et al.: Conflicting Findings on an Intermediate Dose of Rifampicin for Pulmonary Tuberculosis

Por Velásquez, Gustavo E., Brooks, Meredith B., Coit, Julia M., Sánchez Garavito, Epifanio, Calderón, Roger I., Jiménez, Judith, Tintaya, Karen, Peloquin, Charles A., Osso, Elna, Lecca, Leonid, Davies, Geraint R., Mitnick, Carole D.
Publicado no Am J Respir Crit Care Med (2019)

Evaluation of high-dose rifampin in patients with new, smear-positive tuberculosis (HIRIF): study protocol for a randomized controlled trial

Por Milstein, Meredith, Lecca, Leonid, Peloquin, Charles, Mitchison, Denis, Seung, Kwonjune, Pagano, Marcello, Coleman, David, Osso, Elna, Coit, Julia, Vargas Vasquez, Dante Elmo, Sanchez Garavito, Epifanio, Calderon, Roger, Contreras, Carmen, Davies, Geraint, Mitnick, Carole D.
Publicado no BMC Infect Dis (2016)

ERS Special Article. Efficacy and Safety of High-Dose Rifampin in Pulmonary Tuberculosis. A Randomized Controlled Trial

Por Velásquez, Gustavo E., Brooks, Meredith B., Coit, Julia M., Pertinez, Henry, Vargas Vásquez, Dante, Sánchez Garavito, Epifanio, Calderón, Roger I., Jiménez, Judith, Tintaya, Karen, Peloquin, Charles A., Osso, Elna, Tierney, Dylan B., Seung, Kwonjune J., Lecca, Leonid, Davies, Geraint R., Mitnick, Carole D.
Publicado no Am J Respir Crit Care Med (2018)